FAQ

clinafloxacin

Known as: 3-Quinolinecarboxylic acid, 7-(3-amino-1-pyrrolidinyl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-, 7-(3-amino-1-pyrrolidinyl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 7-(3-aminopyrrolidin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2017
010203019932017

Related topics

Related topics

6 relations

Narrower (3)

AM 1091CI 960PD 127,391

Broader (3)

Anti-Bacterial AgentsFluoroquinolonesTopoisomerase II Inhibitors

Related mentions per year

Related mentions per year

1937-2018
19401960198020002020
clinafloxacin
Fluoroquinolones
Anti-Bacterial Agents
CI 960
PD 127,391
Topoisomerase II Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Clinafloxacin for the treatment of bacterial endocarditis.
We report the results of a prospective, multicenter trial assessing intravenous and oral clinafloxacin treatment for infective… (More)
Is this relevant?
2001
2001
Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections.
OBJECTIVE Clinafloxacin is a novel quinolone with wide activity against the plethora of microorganisms encountered in… (More)
Is this relevant?
2001
2001
Efficacy of moxifloxacin, trovafloxacin, clinafloxacin and levofloxacin against intracellular Legionella pneumophila.
This study compares the in vitro activity of novel fluoroquinolones against clinical Legionella pneumophila isolates. We… (More)
Is this relevant?
2000
2000
In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae.
Ability of daily sequential subcultures in subinhibitory concentrations of clinafloxacin, ciprofloxacin, and trovafloxacin to… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2000
2000
Comparative therapeutic efficacy of clinafloxacin in a pneumococcal meningitis mouse model.
The therapeutic efficacy of clinafloxacin, a fluoroquinolone in clinical trials, was compared with that of ciprofloxacin and… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae.
We examined the response of Streptococcus pneumoniae 7785 to clinafloxacin, a novel C-8-substituted fluoroquinolone which is… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
1998
1998
In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.
On 10% oleic acid-albumin-dextrose-catalase-enriched 7H11 agar medium, the MIC at which 90% of the isolates are inhibited for 20… (More)
Is this relevant?
1998
1998
Comparative activities of clinafloxacin against gram-positive and -negative bacteria.
Activities of clinafloxacin, ciprofloxacin, levofloxacin, sparfloxacin, trovafloxacin, piperacillin, piperacillin-tazobactam… (More)
Is this relevant?
1998
1998
Pharmacokinetics and inflammatory fluid penetration of clinafloxacin.
A single 200-mg dose of clinafloxacin was given orally to each of nine healthy male volunteers, and the concentrations of the… (More)
  • figure 1
  • table 1
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin.
The in-vitro activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and… (More)
Is this relevant?